# Albumin for Intracerebral Hemorrhage Intervention

> **NCT00990509** · PHASE2 · TERMINATED · sponsor: **Georgetown University** · enrollment: 14 (actual)

## Conditions studied

- Intracerebral Hemorrhage

## Interventions

- **DRUG:** Albumin
- **DRUG:** Placebo
- **PROCEDURE:** Brain MRI with and without contrast

## Key facts

- **NCT ID:** NCT00990509
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Enrollment was stopped due to low recruitment and the PI's move to a different institution.
- **Last updated:** 2014-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00990509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00990509, "Albumin for Intracerebral Hemorrhage Intervention". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00990509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*